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ABSTRACT
Observation-based early warning scoring systems (EWSS) have been developed to improve the outcome of
critically ill patients by triggering early critical care intervention. To date, none of these scoring systems have
been evaluated in cancer patients or stem cell transplant (SCT) recipients. The aim of this study was to validate
3 established EWSS (modified early warning score [MEWS], patient-at-risk score [PARS], and Leed’s early
warning score [LEWS]) in adult recipients of Allogeneic SCT (Allo-SCT) and to determine their usefulness at
predicting survival. We retrospectively analyzed the physiologic observations during the initial admission of 43
Allo-SCT recipients. Respiratory dysfunction was the most common (40 patients, 93%) event. All 3 EWSS
revealed high accuracy in predicting in-hospital survival. The cutoff level associated with a high risk of
in-hospital mortality was 7. Of 8 patients with a LEWS  7, 6 died during their initial admission, whereas no
patient with a lower score died (specificity 95%, sensitivity 100%). Acute clinical deterioration during the initial
admission appeared to have an adverse effect on overall survival: in-hospital survivors with a LEWS >3 during
their admission had a shorter median survival than patients with LEWS <3, P  .018. This is the first study to
validate EWSS in Allo-SCT and demonstrate that these systems are highly predictive of in-hospital and overall
survival.
© 2007 American Society for Blood and Marrow Transplantation
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Allogeneic stem cell transplantation (Allo-SCT) is
potentially curative treatment for several hemato-
ogic malignancies. However, despite recent ad-
ances in the outcome of Allo-SCT recipients, it is
till associated with a signiﬁcant nonrelapse mortal-
ty (NRM) of approximately 30% [1]. Therefore
llo-SCT is conducted in specialized units under
igh-dependency conditions with a higher level of
ursing care and standardized protocols to deal with
he threat of life-threatening complications (infec- A
68ion, acute graft-versus-host disease [aGVHD]).
umerous pretransplant, disease-speciﬁc scoring
ystems exist to generate risk categories for patients
ndergoing Allo-SCT [2]. To date, no posttrans-
lant scoring system has been validated to detect
arly features of transplant-related critical illness.
Despite careful patient selection, a signiﬁcant
umber of Allo-SCT recipients develop an acute crit-
cal illness and are frequently referred to the intensive
are unit (ICU) for high-dependency supportive care,
specially in the setting of multiorgan dysfunction.
lthough the previously reported 83% mortality [3] of
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Early Warning Scores in Allo-SCT Recipients 569entilated Allo-SCT recipients has decreased to 62%
n a recent study [4], the outcome of critically ill
llo-SCT patients is poor.
In the setting of ICU medicine several scoring
ystems have been developed to determine the out-
ome of critically ill patients. The best known and
ost widely used score is the APACHE score, com-
rising a variety of observational and laboratory values
aken at admission to ICU [5]. Although it is com-
only used for global comparison of ICU popula-
ions, the score has not proved to be helpful for indi-
idual risk assessment [6]. This particularly appears to
e the case for Allo-SCT recipients, as they have a
orse prognosis than their score would predict [7]. In
ddition to these inaccuracies, common ICU scores
re not validated to predict impending critical illness
ecause they deal with patients who already are criti-
ally ill. On the other hand, it seems reasonable to
etect patients at risk as early as possible to allow for
peciﬁc action to be taken to prevent necessity of ICU
dmission. Recently, scoring systems termed early
arning scores (EWS) have been described, aiming at
arly identiﬁcation of patients with impending critical
llness.
Because most patients under the care of internal
edicine and general surgical specialties who become
ritically ill during their hospital stay show signiﬁcant
linical deterioration in the 24 hours prior to cardio-
ulmonary arrest or need for intensive care treatment
8], EWS systems consisting of nursing observations
ave been designed and implemented recently. Their
im is to identify at-risk patients early and take appro-
riate action including involvement of an intensive
are outreach team. Morgan et al [9] were the ﬁrst to
escribe an EWS system, which has been adopted by
able 1. Modiﬁed Early Warning Score (MEWS)
Score 3 2 1
eart rate (beats/min) <40 41-50
ystolic blood pressure (mmHg) <70 70-80 81-100
espiratory rate (min1) <9
emperature (°C) <35
evel of consciousness
able 2. Patient-at-Risk Score (PARS)
Score 3 2 1
eart rate (beats/min) <40 40-49
ystolic blood pressure
(mmHg) <70 70-79 80-99
espiratory rate (min1) <10
xygen saturation (%) <85 85-89 90-94
emperature (°C) <35 35-35.9
rine output (ml*kg1*h1) nil <0.5 Normally dialys
dependent
evel of consciousness Confusionthers [10] and broadly used as modiﬁed early warning
core (MEWS; Table 1). Recently, Goldhill et al [11]
ave reported a slightly different system termed pa-
ient-at-risk (PAR) score with different scores for sim-
lar observations and the addition of urinary output
Table 2). Leeds University teaching hospitals imple-
ented a third scoring system (Leeds early warning
core, LEWS) in 2001, which aims to improve the
implicity of the MEWS, whereas retaining its sensi-
ivity [12]. The LEWS is illustrated in Table 3.
One advantage of these EWS systems over estab-
ished scores such as APACHE or SOFA is their
implicity and ease of calculation from common clin-
cal observations. Also, they have been designed to
stimate the likelihood of a patient’s deterioration
rior to admission to the ICU, whereas most scores
sed in intensive care medicine have been validated
or the ﬁrst 24 hours on the ICU and aim to predict
CU outcome [5]. As stated above, it seems that allo-
eneic stem cell recipients have a worse outcome than
heir APACHE score would predict, making estab-
ished scores less reliable in this setting [7]. Because
his might be true for EWS systems as well, an eval-
ation in this particular patient group is warranted.
enerally, there is little validation of EWS systems in
ifferent patient settings. Subbe et al [10] studied the
EW score in medical patients admitted to a medical
dmission ward, whereas Stenhouse et al [13] studied
he same score in surgical patients and found the
ecessity to include urinary output and changes to the
coring of blood pressure and temperature to their
core after 1 month of prospective study. Goldhill et al
11] studied their score on 1047 ward patients assessed
y the outreach team [11]. Although a large study, this
urvey only includes patients who were already iden-
1 2 3
00 101-110 111-130 >130
99 >200
4 15-20 21-29 >30
8.4 >38.5
rt Reacting to voice Reacting to pain Unresponsive
0 1 2 3
0-99 100-114 115-129 >130
0-179 >180
0-19 20-29 30-39 >40
>95
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M. Von Lilienfeld-Toal et al.570iﬁed as at-risk patients, and therefore, gives no infor-
ation about the patients who were not identiﬁed as
ritically ill.
In the present study, we investigated 3 EWS sys-
ems to (1) identify the best discriminator between
urvivors and nonsurvivors in the well-deﬁned setting
f Allo-SCT, (2) describe the changes of scores and
hus the clinical status of the patient during the course
f the hospital stay, and (3) evaluate the inﬂuence of
cute clinical deterioration during the initial hospital
dmission on overall survival of Allo-SCT.
ATERIALS AND METHODS
atients
Between February 2002 and August 2004, adult
atients undergoing Allo-SCT for malignant and
onmalignant hematologic conditions were eligible
or this restrospective case analysis study. Case notes
f patients were analyzed for clinical data, disease
haracteristics, and outcome, and physiologic obser-
ations (temperature, blood pressure, heart rate, re-
piratory rate, oxygen saturation, oxygen therapy, uri-
ary output, level of consciousness) were documented
or each in-hospital day until day 35 postgraft. The
orst value of each day was recorded. Missing values
ere assumed to be normal. Survival and duration in
he hospital were calculated from the day of transplan-
ation (day 0). Also, engraftment was assumed on the
ay the neutrophils reached 0.5 G/L and time to
ngraftment was again counted from day 0.
Three EWS (LEWS [12], MEWS [10], and PARS
11]) were calculated as described before for each day.
he values and their scoring systems are depicted in
ables 1-3. The maximum score for each patient was
etermined and further evaluated.
tatistical Analysis
All statistical analyses were performed using SPSS
version 12.0 for Windows, Munich, Germany).
NOVA, Fisher’s exact, chi-square, and Mann-Whit-
ey tests were used to test for differences, a 2-sided
-value .05 was considered signiﬁcant. Receiver op-
able 3. Leeds Early Warning Score (LEWS)
Score 3 2 1
eart rate (beats/min) <40 41-50
ystolic blood pressure
(mmHg) <70 70-80 81-10
espiratory rate (min1) <8 8-11
xygen saturation (%) <85 85-89 90-94
espiratory support BIPAP/CPAP Hi-Flow Oxygen Th
rine output in last 4
hours (mL) <80 80-120 120-20
evel of consciousness Confusiorating characteristic (ROC) curves are plots of the tensitivity of a test versus its false-positive rate for all
ossible cutoff levels and are used as a means to esti-
ate the accuracy of a diagnostic test [14]. They were
lotted to determine the area under the curve (AUC) for
utoff levels for the optimal combination of sensitivity
nd speciﬁcity. A 2  2 table was used to calculate the
ensitivity, speciﬁcity, and negative/positive predictive
alue for a given cutoff level. Survival analysis was
arried out using the Kaplan-Meier method; the log-
ank test was used to test for differences.
ESULTS
atient Characteristics
Data from 43 patients were available for analysis.
atient characteristics are summarized in Table 4.
he median age of the patients was 40 years (inter-
uartile range [IQR] 29-49). Almost half of the
ransplants were carried out for acute leukemia (acute
ymphoblastic leukemia [ALL]/acute myelogenous
eukemia n  21, Hodgkin’s disease/non-Hodgkin’s
ymphoma n  10, multiple myeloma n  4, chronic
yeloid leukemia n  7, severe aplastic anaemia n 
). Most patients (n  29) received their graft from a
elated donor. Of those, more than half (n  17)
eceived a reduced intensity conditioning. Among pa-
ients with an unrelated donor (n  14) the distribu-
ion was similar: more than half (n  8) received a
educed intensity conditioning. Full intensity condi-
ioning included fractionated total body irridation
TBI) (12-14.4 Gy) with either cyclophosphamide
120 mg/m2) for myeloid malignancies or etoposide
60 mg/kg) for ALL. GVHD prophylaxis utilized cy-
losporine and short-course methotrexate. For re-
uced intensity conditioning, patients received i.v. ﬂu-
arabine (150 mg/m2) and melphalan (140 mg/m2)
ith alemtuzumab (MabCAMPATH, Schering, UK)
t a dose of 60-100 mg i.v. GVHD prophylaxis was
iclosporin alone.
On average, patients stayed in the hospital for 3
eeks after transplant (median day of discharge day 22
QR 19-34). Patients receiving reduced intensity con-
itioning were discharged a few days earlier than pa-
0 1 2 3
51-100 101-110 111-130 >130
101-179 180-199 200-220 >220
12-20 21-25 26-30 >30
>95
>800
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Early Warning Scores in Allo-SCT Recipients 571n day 21 IQR 18-36 versus discharge on day 24 IQR
0-35, respectively, P  .2). Day 100 mortality was
2% (5 patients), whereas day 365 mortality was
5% (15 patients). The LEW scores were recorded
hroughout the transplant in-patient period until day
35 and not perimortal in those patients who did not
urvive, and although the ﬁrst 2 deaths occurred on
ay34, all other nonsurvivors died later during their
ourse in the hospital.
Six patients died during the initial admission for
llogeneic bone marrow transplantation (BMT) after a
edian of 50 days (IQR 36-76). Patients who died
uring their stay in the hospital were older (49 years
IQR 39-56] versus 39 years [IQR 29-46]) and more
ikely to suffer from multiple myeloma or ALL, but
id not show any signiﬁcant differences in stage of
isease. In addition, nonsurvivors did not have a
onger duration of neutropenia, more febrile episodes,
r more mucositis (P  .05). The higher frequency of
able 4. Patient Characteristics
Patient Characteristics
All Patients n
N  43
ale 22 (51.2)
isease
AML/MDS 14 (32.6)
ALL 7 (16.3)
HD 4 (9.3)
NHL 6 (14)
MM 4 (9.3)
CML 7 (16.3)
SAA 1 (2.3)
tage
CR1 14 (32.6)
CR2 5 (11.6)
Chronic phase 5 (11.6)
Active disease/refractory 18 (41.9)
onor
Sib 29 (67.5)
MUD 14 (32.6)
onditioning
Full intensity 18 (41.9)
RIC 25 (58.1)
edian (IQR)
Age 40 (29-49)
Duration neutropenia 11 (9-17)
Duration admission 22 (19-34)
bservations
Maximum heart rate (min1) 110 (100-13
Maximum temperature (°C) 38.5 (38-39)
Minimum systolic blood pressure (mmHg) 95 (85-100
Maximum respiratory rate (min1) 24 (23-28)
Minimum oxygen saturation (%) 94 (90-95)
Minimum urinary output in 4 hours (mL) 170 (119-17
omplications n (%)
Pneumonia 7 (16.3)
Mucositis 25 (58.1)
Acute GVHD 27 (62.8)
Septicemia 21 (48.8)
VHD indicates graft-versus-host disease.epticemia among nonsurvivors was not statistically iigniﬁcant. However, there was a higher incidence of
neumonia, a complication that occurred in only 10%
f hospital survivors but in half of the nonsurvivors.
The main cause of death was aGVHD (biopsy
roven, n  3); 1 patient died of fungal pneumonia, 1
f septicemia, and 1 of intracranial bleeding. Most
atients, however, suffered from more than 1 compli-
ation (see Table 4). Although aGVHD was a major
ause of death, there was no signiﬁcant difference
etween the frequency or the grade of GVHD (P 
05) in survivors and nonsurvivors. Four patients had
een admitted to the ICU, 2 of whereas died in the
CU and 2 after discharge back to the ward. None of
he survivors were admitted to the ICU.
bservations
Values for body temperature, heart rate, blood
ressure, and urinary output were recorded in every
Hospital Survivors n (%)
N  37
Nonsurvivors n (%)
N  6 P
19 (52.8) 3 (50) .645
.04
12 (32.4) 2 (33.3)
5 (13.5) 2 (33.3)
4 (10.8)
6 (16.2)
2 (5.4) 2 (33.3)
7 (18.9)
1 (2.7)
.753
12 (32.4) 2 (33.3)
4 (10.8) 1 (16.7)
5 (13.5)
15 (42.7) 3 (50)
.665
26 (70.3) 3 (50)
11 (29.7) 3 (50)
.209
17 (45.9) 1 (16.7)
20 (54.1) 5 (83.3)
39 (29-46) 49 (39-56) .09
11 (9-17) 10 (7-17) .488
21 (19-28) 49 (36-76) .001
110 (100-128) 160 (124-178) <.001
38.5 (38-39) 39 (38.5-39.5) .156
95 (86-100) 90 (88-96) .128
24 (22-26) 30 (28-36) <.001
95 (92-96) 88 (82-89) <.001
176 (123-209) 113 (79-202) .320
4 (10.8) 3 (50) .045
22 (59.5) 3 (50) .683
22 (59.5) 5 (83.3) .386
16 (43.2) 5 (83.3) .095(%)
0)
)
9)npatient every day. In contrast, some missing values
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M. Von Lilienfeld-Toal et al.572ere encountered for respiratory rate (35-44% of val-
es missing) and oxygen saturation (7-19% of values
issing). However, missing values were always in pa-
ients otherwise well, and were therefore assumed to
e normal.
Predictably, all patients had some evidence of clin-
cal deterioration during their stay in the bone marrow
ransplantation unit. Sixty-six febrile eposides were
ocumented in 38 patients: 20 patients experienced a
ingle episode, 8 experienced 2 episodes, and 10 ex-
erienced 3 episodes. Most of those febrile episodes
ccurred in the neutropenic phase; only 3 patients had
febrile episode after resolution of neutropenia. Al-
hough all patients experienced a deterioration in their
linical status, there were clear differences among sur-
ivors and nonsurvivors. Nonsurvivors were more
ikely to have severe respiratory impairment and a
igher heart rate (Table 4). This was also reﬂected in
he measures taken accordingly: all the nonsurvivors
eceived oxygen therapy, whereas 29 survivors (80%)
id not need any respiratory support (P  .001).
In addition, none of the survivors had an impair-
ent in their neurologic status, whereas 4 nonsurvi-
ors were confused or only responded to pain at some
tage during their in-hospital stay (P  .016).
WS
Maximum values for LEWS, MEWS, and PARS
uring the admission for BMT are presented in Table
. Whereas 2 patients did not score any points accord-
ng to LEWS, all patients scored at least 1 according
o MEWS and PARS. In contrast, scores of survivors
nd nonsurvivors overlapped more with MEWS and
ARS than with LEWS (Table 5). To determine the
ccuracy of these scoring systems for our patient pop-
lation, an ROC curve was drawn. All 3 scoring sys-
ems revealed AUC 0.9, with LEWS appearing to
e the best discriminator (Figure 1). The best cutoff
evels for prediction of survival of the hospital stay
ere deduced from the ROC curve, and negative and
ositive predictive values were determined for each
utoff level (Table 6). Clearly, a LEW score of 7 has
he highest predictive value: all of the patients with a
aximum LEWS below 7 survived the hospital stay,
hereas 6 of 8 patients with maximum LEWS of 7 or
bove died. One survivor of a LEWS 6 died 6
onths later, the other 1 on day 400, both of pneu-
onia. Thus, the median survival for patients with
EWS 6 is 53 days (not reached for patients with
EWS 6, P  .001; Figure 2).
ime Course of LEW Scores during
ospital Admission
To investigate the time course of LEW scores and
heir inﬂuence on hospital survival, the median scores
or each day were plotted for survivors and nonsurvi- pors (Figure 3). Clearly, a rise in LEW scores can be
oted after the ﬁrst week posttransplant. Most hospi-
al survivors then achieve normal values by day 13,
hich coincides with the median day of engraftment
median day of neutrophils0.5 G/L was day 14, IQR
1-18). In contrast, LEW scores of nonsurvivors stay
levated even after resolution of neutropenia.
nfluence of LEWS on Long-Term Survival
The cutoff level for intervention (eg, involvement
f the outreach team) has generally been set at a score
f 3 or above, because those patients seem to be at a
ritical clinical state with higher risk of cardiopulmo-
ary arrest [10,15]. We were interested in the effect of
critical deterioration in the clinical status during the
ourse of the initial admission on long-term survival.
welve hospital survivors died within our observation
ime. The most common cause of death among hos-
ital survivors was an infectious complication (pneu-
onia in 4 patients, other infections in 2 patients).
ther causes included GVHD (1 patient), relapse (2
able 5. Maximum Values for Various Risk Scores
Maximum
Score
All Patients
n (%) N  43
Hospital Survivors
n (%) N  37
Nonsurvivors
n (%) N  6
EWS
0 2 (4.7) 2 (5.4) 0
1 7 (16.3) 7 (18.9) 0
2 7 (16.3) 7 (18.9) 0
3 3 (7) 3 (8.1) 0
4 12 (27.9) 12 (32.4) 0
5 3 (7) 3 (8.1) 0
6 1 (2.3) 1 (2.7) 0
7 2 (4.7) 0 2 (33.3)
8 3 (7) 1 (2.7) 2 (33.3)
9 0 0 0
10 3 (7) 1 (2.7) 2 (33.3)
EWS
0 0 0 0
1 1 (2.3) 1 (2.7) 0
2 8 (18.6) 8 (21.6) 0
3 10 (23.3) 10 (27) 0
4 6 (14) 6 (16.2) 0
5 4 (9.3) 3 (8.1) 1 (16.7)
6 7 (16.3) 6 (16.2) 1 (16.7)
7 5 (11.6) 2 (5.4) 3 (50)
8 1 (2.3) 0 1 (16.7)
9 1 (2.3) 1 (2.7) 0
ARS
0 0 0 0
1 2 (4.7) 2 (5.4) 0
2 2 (4.7) 2 (5.4) 0
3 10 (23.3) 10 (27) 0
4 8 (18.6) 8 (21.6) 0
5 6 (14) 5 (13.5) 1 (16.7)
6 7 (16.3) 7 (18.9) 0
7 2 (4.7) 1 (2.7) 1 (16.7)
8 2 (4.7) 0 2 (33.3)
9 2 (4.7) 1 (2.7) 1 (16.7)
10 2 (4.7) 1 (2.7) 1 (16.7)atients), and pulmonary hemorrhage (1 patient). In 2
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Early Warning Scores in Allo-SCT Recipients 573atients the cause of death remained unknown. An
OC curve of the maximum LEW score during hos-
ital admission in hospital survivors revealed a cutoff
evel of 4 and above for most accurate prediction of
verall survival (AUC 0.715, P  .048, sensitivity
0%, speciﬁcity 66%, positive prediction value 47%,
egative prediction value 89%). To determine the
verall survival rate among hospital survivors, a
aplan-Meier survival curve was plotted comparing
hose patients who had a LEWS 3 during their
ospital stay and those who only achieved a LEWS
3 (Figure 4). Interestingly, the inﬂuence of clinical
eterioration during the initial admission on long-
erm outcome seems to last for the entire ﬁrst year
osttransplant, although the median interval between
he ﬁrst day with LEWS 3 and death was 145 days
IQR 41-233).
ISCUSSION
This study evaluating clinical observations in pa-
ients receiving Allo-SCT found abnormal observa-
igure 1. ROC curve for Leeds modiﬁed early warning score (LEW
ospital survival. AUC: 0.964 for LEWS (P  .001), 0.894 for ME
able 6. Sensitivity, Speciﬁcity, Positive Predictive Value (PPV), and N
he ROCC
TP/FN FP/TN
EWS score 7 or above 6/0 2/35
EWS score 7 or above 45/2 3/34
ARS score 7 or above 5/1 3/34P indicates true positive; FN, false negative; FP, false positive; TN, trueions in every patient episode, compounding the un-
erstanding of the need for high dependency care in
his group of patients. The most divergent were re-
piratory parameters: patients who did not survive the
ospital stay had signiﬁcantly higher respiratory rates,
ower oxygen saturations, and required oxygen ther-
py more often. In contrast, in observations regarding
he cardiovascular system, differences could only be
ound in the heart rate but not in the systolic blood
ressure. Also, fever was not signiﬁcantly more com-
on or more severe in nonsurvivors and renal impair-
ent proved to be only marginally different between
urvivors and nonsurvivors.
Deviations in clinical observations can be weighted
n different EWS systems to determine the likelihood
f cardiopulmonary arrest. Most patients on general
ards do not have any of the abnormalities measured
y EWS, and therefore can be classiﬁed as low risk. In
study by Goldhill and McNarry [16], only 11% of
atients on general wards were found to have a PAR
core of 3 or more. In contrast, only 4 patients in our
atient population scored 3 in the PARS, leaving
odiﬁed early warning score (MEWS), and PARS for prediction of
d 0.905 for PARS, P  .002 for both scoring systems.
Predictive Value (NPV) for the Cutoff Levels as Determined from
Specificity Sensitivity PPV NPV
95% 100% 75% 100%
92% 67% 57% 94%
92% 83% 63% 97%S), megativenegative.
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M. Von Lilienfeld-Toal et al.5741% to score 3 or more. This illustrates the critical
ituation of allo-SCT recipients during the initial 4
eeks posttransplantation, and emphasizes the impor-
ance of a high-dependency setting for allogeneic
ransplantations.
To evaluate the accuracy of different EWS sys-
ems as reported in the literature, we calculated
EWS, MEWS, and PARS for each inpatient day
ntil day 35 posttransplantation. Although we achieved
igher AUCs for MEWS and PARS than reported in
he literature [10,11], the most reliable scoring system
roved to be the Leeds-based LEWS. This might be
rom the stronger emphasis on respiratory problems
nd the omission of temperature, which was not dif-
erent in survivors and nonsurvivors in our patient
opulation. In summary, LEWS values reﬂect the
igure 2. Survival of patients with or without a maximum LEWS6
6 and not reached for patients with LEWS 6 (P  .001 log-ran
igure 3. LEW scores during the ﬁrst 35 days posttransplant in hos
ifferences are signiﬁcant on day 9 with P  .05 and from day 11 onwareverity of illness accurately, and may therefore help
o identify patients at risk early and reliably, alerting
he medical team to closer monitoring and intensiﬁed
are.
To date, EWS systems have been evaluated in
atients admitted to a medical admissions unit [10]
nd in inpatients on a general [11] and a surgical [13]
ard. There are no data regarding patients with ma-
ignancies receiving chemotherapy or a hematopoetic
tem cell transplantation. Previous studies associated a
core of 5 and above on admission [10] or 2 and above
n the inpatient setting [11] with an increased risk in
ospital mortality. In contrast to others, we found a
uch higher cutoff level to predict death during the
ospital stay. Whereas Goldhill et al [11] reported a
% mortality rate among patients with a PAR score of
n Meier plot). Median survival was 53 days for patients with LEWS
rvivors and nonsurvivors. Median values  quartiles are presented.(Kaplapital su
d with P  .01.
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Early Warning Scores in Allo-SCT Recipients 575and Subbe et al [10] reported a mortality rate of
pproximately 4% in patients with a MEW score of
-2 on admission, the lowest maximum score a non-
urvivor in our population achieved was 5 (MEWS
nd PARS). The best cutoff level for prediction of
ospital mortality in our analysis was a score of 7 or
bove in LEWS, MEWS, or PARS. Regarding sensi-
ivity, speciﬁcity, and predictive values, a LEW score
f 7 and above was most accurate in predicting hos-
ital mortality and survival. This surprisingly high
utoff level might reﬂect the intensive monitoring of
ritical parameters associated with the high-depen-
ency style care given to Allo-SCT recipients, and
herefore cannot be adopted in other clinical situa-
ions.
In an attempt to determine the time frame in
hich patients were most likely to deteriorate, we
lotted median LEWS values of each day. From this
raph the most dangerous time appears to be the
econd week after transplantation (Figure 3). With
ngraftment, the scores of hospital survivors returned
o normal, whereas those of the nonsurvivors re-
ained elevated. It should be noted that none of the
atients in this population died during the neutro-
enic phase. Thus, the feared period of profound
eutropenia does not appear to be as critical as ex-
ected. This is possibly a result of improved and
ell-standardized patient care during that period. In
ontrast, the complications resulting in treatment-
elated mortality after resolution of neutropenia and
he actions taken to treat them seem less well deﬁned
nd measures less standardized.
Because the EWS system as a measure of acute
llness had such a high predictive value for hospital
igure 4. Survival of patients after hospital discharge with regard t
atients with LEWS 3, and not reached for patients with LEWSurvival, we were interested in its accuracy in predict- ing overall survival. Interestingly, hospital survivors
ith a LEW score of 4 and above had a signiﬁcantly
ower overall survival. Therefore, deterioration of ob-
ervational ﬁndings during the initial admission might
eﬂect a susceptibility to subsequent complications.
his seems to be the case, particularly for infectious
omplications, as 50% of hospital survivors who died
fter discharge died of an infection. Obviously, this
llustrates the need for closer medical observation and
ossibly more immediate intervention in this group of
atients at least in the ﬁrst year posttransplantation. It
ould be desirable to be able to determine the group
f patients likely to develop severe acute illness before
ransplantation. However, in our analysis the EWS
ystems were not capable of distinguishing survivors
nd nonsurvivors early in their in-hospital course be-
ause in both groups scores were low in the ﬁrst week
fter transplantation. On the other hand, EWS clearly
istinguished patients at higher risk later during their
dmission but prior to their ultimate deterioration,
eaving some time for appropriate action. In previous
tudies, the measures taken because of a raised EWS
sually included the involvement of an outreach team.
owever, no predeﬁned actions were implemented,
nd this might be the reason why results vary with
egard to the outcome of patients at risk after intro-
uction of EWS. It seems likely, though, that a pre-
peciﬁed plan of action will improve outcome of de-
eriorating patients similar to sepsis patients subjected
o early goal-directed therapy [17]. Prospective studies
re needed to assess the best mode of action in the
pecial setting of Allo-SCT recipients.
Although this study is a retrospective analysis and
he number of patients is small, there are several key
LEWS value during admission. Median survival was 663 days for
 .0179).o theirssues raised. First, this is the ﬁrst study evaluating
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M. Von Lilienfeld-Toal et al.576ifferent EWS systems in a deﬁned group of patients
ith hematologic malignancies. Second, it is the ﬁrst
tudy to describe a time course of EWS during in-
ospital stay in Allo-SCT recipients, and although
ther studies in the general medical population have
ssessed their usefulness in critically ill patients, this
tudy determined the scores for all patients regardless
f a development of an acute critical illness. There-
ore, this study describes the effect of severe acute
llness during the admission for Allo-SCT on the
verall survival of patients, and provides a clinically
seful tool to identiﬁy those at risk and develop a more
irected intensive strategy for those at greatest risk.
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